"Hotspots" Highlight Need for Targeted Efforts to Promote Colorectal Cancer Screening
July 8th 2015Researchers have identified three "hotspots" in the United States where progress on reducing death rates from colorectal cancer have lagged, shining a light on areas of the country where efforts to increase screening uptake and promote healthier lifestyles could make a big difference.
The Goodwill of Strangers Helps Build a Unique Resource for Cancer Research
July 3rd 2015Thousands of women have made the selfless choice to literally donate a precious piece of themselves by giving a breast tissue sample to the Susan G. Komen Tissue Bank at the Indiana University Melvin and Bren Simon Cancer Center, a unique resource for researchers worldwide.
Single-Dose Fosaprepitant Effective in Preventing CINV with Moderately Emetogenic Chemotherapy
July 1st 2015A single intravenous dose of fosaprepitant dimeglumine was shown to be superior to placebo when either were combined with other anti-vomiting agents for protection against chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy.
More Sensitive Stress-Management Tools Needed for Latina Women With Breast Cancer
June 26th 2015A study looking at the care experiences and possible stressors for Latina women undergoing chemotherapy to treat their breast cancer has found that this patient population feels particular stress related to their family and other interpersonal relationships.
Prostate Cancer Foundation Steps Into the Ring to Knock Out Prostate Cancer for Good
June 25th 2015The Prostate Cancer Foundation is throwing a one-two punch to knock out prostate cancer for good with the recent production of a public service announcement featuring boxing legend and five-time heavyweight champion of the world Evander Holyfield.
Relieving Nausea With Olanzapine in Patients Treated for Head and Neck Cancer
June 18th 2015Nausea and vomiting associated with anticancer therapies continue to be among patients' most troubling symptoms. Findings of a clinical trial found that olanzapine demonstrated comparative benefits in relieving these symptoms.